KELLY HARDESTY: Open Payments
NPI 1265957971 · KOUTS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,333 in 84 payments from 9 companies in 2025. Trend: 2023 $1,720 · 2024 $1,835 · 2025 $2,333
Food & beverage: $2,331Education: $2
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 27 | $607 |
| ViiV Healthcare Company | 25 | $580 |
| Gilead Sciences, Inc. | 9 | $503 |
| ABBVIE INC. | 5 | $237 |
| Shionogi Inc | 10 | $188 |
| Melinta Therapeutics, LLC | 5 | $144 |
| Aimmune Therapeutics, Inc. | 1 | $35 |
| Novo Nordisk Inc | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
Products named: NUZYRA, DOVATO, Fetroja, EMBLAVEO, Kimyrsa, DALVANCE, APRETUDE, VOWST.
Industry payments across IN — which companies pay providers there.
